Early Decision Making in a Randomized Phase II Trial of Atezolizumab in Biliary Tract Cancer Using a Tumor Growth Inhibition-Survival Modeling Framework.
Saved in:
| Title: | Early Decision Making in a Randomized Phase II Trial of Atezolizumab in Biliary Tract Cancer Using a Tumor Growth Inhibition-Survival Modeling Framework. |
|---|---|
| Authors: | Shemesh CS; Clinical Pharmacology, Genentech Inc., South San Francisco, California, USA., Chan P; Clinical Pharmacology, Genentech Inc., South San Francisco, California, USA., Marchand M; Certara Strategic Consulting, Paris, France., Gonçalves A; Certara Strategic Consulting, Paris, France., Vadhavkar S; Clinical Pharmacology, Genentech Inc., South San Francisco, California, USA., Wu B; Clinical Pharmacology, Genentech Inc., South San Francisco, California, USA., Li C; Clinical Pharmacology, Genentech Inc., South San Francisco, California, USA., Jin JY; Clinical Pharmacology, Genentech Inc., South San Francisco, California, USA., Hack SP; Product Development Oncology, Genentech Inc., South San Francisco, California, USA., Bruno R; Clinical Pharmacology, Genentech-Roche, Marseille, France. |
| Source: | Clinical pharmacology and therapeutics [Clin Pharmacol Ther] 2023 Sep; Vol. 114 (3), pp. 644-651. Date of Electronic Publication: 2023 Jun 02. |
| Publication Type: | Randomized Controlled Trial; Multicenter Study; Clinical Trial, Phase II; Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Wiley Country of Publication: United States NLM ID: 0372741 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1532-6535 (Electronic) Linking ISSN: 00099236 NLM ISO Abbreviation: Clin Pharmacol Ther Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 37212707 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Early Decision Making in a Randomized Phase II Trial of Atezolizumab in Biliary Tract Cancer Using a Tumor Growth Inhibition-Survival Modeling Framework. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Shemesh+CS%22">Shemesh CS</searchLink>; Clinical Pharmacology, Genentech Inc., South San Francisco, California, USA.<br /><searchLink fieldCode="AU" term="%22Chan+P%22">Chan P</searchLink>; Clinical Pharmacology, Genentech Inc., South San Francisco, California, USA.<br /><searchLink fieldCode="AU" term="%22Marchand+M%22">Marchand M</searchLink>; Certara Strategic Consulting, Paris, France.<br /><searchLink fieldCode="AU" term="%22Gonçalves+A%22">Gonçalves A</searchLink>; Certara Strategic Consulting, Paris, France.<br /><searchLink fieldCode="AU" term="%22Vadhavkar+S%22">Vadhavkar S</searchLink>; Clinical Pharmacology, Genentech Inc., South San Francisco, California, USA.<br /><searchLink fieldCode="AU" term="%22Wu+B%22">Wu B</searchLink>; Clinical Pharmacology, Genentech Inc., South San Francisco, California, USA.<br /><searchLink fieldCode="AU" term="%22Li+C%22">Li C</searchLink>; Clinical Pharmacology, Genentech Inc., South San Francisco, California, USA.<br /><searchLink fieldCode="AU" term="%22Jin+JY%22">Jin JY</searchLink>; Clinical Pharmacology, Genentech Inc., South San Francisco, California, USA.<br /><searchLink fieldCode="AU" term="%22Hack+SP%22">Hack SP</searchLink>; Product Development Oncology, Genentech Inc., South San Francisco, California, USA.<br /><searchLink fieldCode="AU" term="%22Bruno+R%22">Bruno R</searchLink>; Clinical Pharmacology, Genentech-Roche, Marseille, France. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%220372741%22">Clinical pharmacology and therapeutics</searchLink> [Clin Pharmacol Ther] 2023 Sep; Vol. 114 (3), pp. 644-651. <i>Date of Electronic Publication: </i>2023 Jun 02. – Name: TypePub Label: Publication Type Group: TypPub Data: Randomized Controlled Trial; Multicenter Study; Clinical Trial, Phase II; Journal Article; Research Support, Non-U.S. Gov't – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Wiley%22">Wiley </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>0372741 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1532-6535 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2200099236%22">00099236 </searchLink><i>NLM ISO Abbreviation: </i>Clin Pharmacol Ther <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=37212707 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1002/cpt.2953 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 644 Titles: – TitleFull: Early Decision Making in a Randomized Phase II Trial of Atezolizumab in Biliary Tract Cancer Using a Tumor Growth Inhibition-Survival Modeling Framework. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Shemesh CS – PersonEntity: Name: NameFull: Chan P – PersonEntity: Name: NameFull: Marchand M – PersonEntity: Name: NameFull: Gonçalves A – PersonEntity: Name: NameFull: Vadhavkar S – PersonEntity: Name: NameFull: Wu B – PersonEntity: Name: NameFull: Li C – PersonEntity: Name: NameFull: Jin JY – PersonEntity: Name: NameFull: Hack SP – PersonEntity: Name: NameFull: Bruno R IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 09 Text: 2023 Sep Type: published Y: 2023 Identifiers: – Type: issn-electronic Value: 1532-6535 Numbering: – Type: volume Value: 114 – Type: issue Value: 3 Titles: – TitleFull: Clinical pharmacology and therapeutics Type: main |
| ResultId | 1 |
